Aim and objective: To compare HbA1c levels with inflammatory markers that include a neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) in controlled and uncontrolled diabetics.
Materials and methods: Eighty-nine patients with type 2 diabetes mellitus (T2DM) were divided into two groups of controlled (HbA1c <7%) and uncontrolled (HbA1c >7%) diabetics. Recent laboratory data were used to collect HbA1c (glycated hemoglobin) levels, leukocyte count (WBC), hemoglobin (Hb), hematocrit (Hct), red blood cell distribution width (RDW), neutrophils, lymphocytes, and monocytes. The NLR and MLR were calculated from the laboratory data.
Results: The mean age in controlled and uncontrolled diabetics was 58.30 and 55.62 years, respectively. The mean NLR in controlled and uncontrolled diabetics was 2.61 and 4.88. The difference was found to be statistically significant (p < 0.05). The mean MLR in controlled and uncontrolled diabetics was 0.2 and 0.24, but the difference was not statistically significant (p > 0.05). A weak positive correlation was found between HbA1c levels and the hematological indices and the results were statistically insignificant.
Conclusion: The study yielded significant results in the difference between controlled and uncontrolled diabetics with respect to NLR. Although there was only a weak positive correlation found between glycated Hb levels and the hematological indices, the results showed that there is a significant difference in the NLR between the two groups. This proves that there is scope for use of these ratios as inflammatory markers in T2DM.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):e442. DOI: 10.1371/journal.pmed.0030442.
Shoelson SE, Lee J, Goldfine AB. Inflammation, and insulin resistance. J Clin Invest 2006;116(7):1793–1801. DOI: 10.1172/JCI29069.
Lontchi-Yimagou E, Sobngwi E, Matsha TE, et al. Diabetes mellitus and inflammation. Curr Diab Rep 2013;13(3):435. DOI: 10.1007/s11892-013-0375-y.
Ziaee A, Ghorbani A, Kalbasi S, et al. Association of hematological indices with prediabetes: a cross-sectional study. Electron Physician 2017;9(9):5206–5211. . Published 2017 10.19082/5206.
Luo Y, She DL, Xiong H, et al. Pretreatment neutrophil to lymphocyte ratio as a prognostic predictor of urologic tumors: a systematic review and meta-analysis. Medicine (Baltimore) 2015;94(40):e1670. DOI: 10.1097/MD.0000000000001670.
Gunduz S, Mutlu H, Tural D, et al. Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer. Asia Pac J Clin Oncol 2015;11(4):288–292. DOI: 10.1111/ajco.12358.
Gu L, Ma X, Wang L, et al. Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model. Oncotarget 2016;8:52094–52103. DOI: 10.18632/oncotarget.10626.
Semeniuk-Wojtaś A, Lubas A, Stec R, et al. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and C-reactive protein as new and simple prognostic factors in patients with metastatic renal cell cancer treated with tyrosine kinase inhibitors: a systemic review and meta-analysis. Clin Genitourin Cancer 2018;16(3):e685–e693. DOI: 10.1016/j.clgc.2018.01.010 ISSN 1558-7673.
Akyel A, Yayla Ç, Erat M, et al. Neutrophil-to-lymphocyte ratio predicts hemodynamic significance of coronary artery stenosis. Anatol J Cardiol 2015;15(12):1002–1007. DOI: 10.5152/akd.2015.5909.
Oylumlu M, Yıldız A, Oylumlu M, et al. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome. Anatol J Cardiol 2015;15(4):277–283. DOI: 10.5152/akd.2014.5366.
Warimwe GM, Fletcher HA, Olotu A, et al. Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS, S malaria vaccine: analysis of pooled phase II clinical trial data. BMC Med 2013;11:184. DOI: 10.1186/1741-7015-11-184.
Demirtas L, Degirmenci H, Akbas EM, et al. Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med 2015;8(7):11420–11427.
Akbas EM, Demirtas L, Ozcicek A, et al. Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. Int J Clin Exp Med 2014;7(7):1794–1801.
Ciray H, Aksoy AH, Ulu N, et al. Nephropathy, but not angiographically proven retinopathy, is associated with neutrophil to lymphocyte ratio in patients with type II diabetes. Exp Clin Endocrinol Diabetes 2015;123(5):267–271. DOI: 10.1055/s-0035-1547257.
Ulu SM, Dogan M, Ahsen A, et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther 2013;15(11):942–947. DOI: 10.1089/dia.2013.0097.
Wang RT, Zhang JR, Li Y, et al. Neutrophil-lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type II diabetes. J Diabetes Complicat 2015;29(2):245–249. DOI: 10.1016/j.jdiacomp.2014.11.006.
Yue S, Zhang J, Wu J, et al. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health 2015;12(8):10009–10019. DOI: 10.3390/ijerph120810009.
Onalan E, Gozel N, Donder E. Can hematological parameters in type II diabetes predict microvascular complication development? Pak J Med Sci 2019;35(6):1511–1515. DOI: 10.12669/pjms.35.6.1150.
Chung FM, Tsai JC, Chang DM, et al. Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care 2005;28(7):1710–1717. DOI: 10.2337/diacare.28.7.1710.
Dada OA, Uche E, Akinbami A, et al. The relationship between red blood cell distribution width and blood pressure in patients with type II diabetes mellitus in Lagos, Nigeria. J Blood Med 2014;5:185–189. DOI: 10.2147/JBM.S67989.
Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020;84:106504. DOI: 10.1016/j.intimp.2020.106504.
Akinci Ozyurek B, Sahin Ozdemirel T, Buyukyaylaci Ozden S, et al. Prognostic value of the neutrophil to lymphocyte ratio (NLR) in lung cancer cases. Asian Pac J Cancer Prev 2017;18(5):1417–1421. Published 2017 May 1 10.22034/APJCP.2017.18.5.1417.
Onsrud M, Thorsby E. Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol 1981;13(6):573–579. DOI: 10.1111/j.1365-3083.1981.tb00171.x. https://www.ncbi.nlm.nih.gov/pubmed/7313552.
Ye G, Chen Q, Chen X, et al. The prognostic role of platelet-to-lymphocyte ratio in patients with acute heart failure: a cohort study. Sci Rep 2019;9(1):10639. DOI: 10.1038/s41598-019-47143-2.
Stojkovic Lalosevic M, Pavlovic Markovic A, Stankovic S, et al. Combined diagnostic efficacy of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV) as biomarkers of systemic inflammation in the diagnosis of colorectal cancer. Dis Markers 2019;2019:6036979. DOI: 10.1155/2019/6036979.
Chen H, Li M, Liu L, et al. Monocyte/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients with non-ST-elevation myocardial infarction. Medicine (Baltimore) 2019;98(26):e16267. DOI: 10.1097/MD.0000000000016267.
Hussain M, Babar MZM, Akhtar L, et al. Neutrophil lymphocyte ratio (NLR): a well assessment tool of glycemic control in type II diabetic patients. Pak J Med Sci 2017;33(6):1366–1370. DOI: 10.12669/pjms.336.12900.
Nguyen DV, Shaw LC, Grant MB. Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol (Lausanne) 2012;3:170. DOI: 10.3389/fendo.2012.00170Published 2012 Dec 21.